Study Details

Back
Study ID FJ-506-LN02
Study Title Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis(Original language of CSR synopsis is Japanese.)
Clinicaltrials.gov Identifier NCT00429377
Compound Name FK506 / tacrolimus
Medical Indication or Disease Lupus nephritis
Study Sponsor Astellas Pharma Inc.
Collaborator Not Applicable
Study Start Date 07-Jul-2003
Study Completion Date 16-May-2005
Clinical Study Result
Select the language
Japanese
Plain Language Summary
Select the language
Not Available

QUICK SEARCH

USEFUL LINKS